Skip to main content
Equibles
TBI logo

TBI · TrueBlue, Inc. · Metrics

Track TBI — free

Use TBI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TBI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.41 +2.57 (+26.12%) Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$301.09M
Shares
30.44M
Volume · Nov 4 250.62K Avg daily vol (3M) 275.93K

TBI metrics

86 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.84
Market cap
$301.09M

Price action

20 metrics
Price change (1W)
-0.9%
Price change (30D)
+7.8%
Price change (3M)
+24.7%
Price change (6M)
+58.8%
Price change (YTD)
+110.8%
Price change (1Y)
+104.9%
Trailing year
Price change (5Y)
-65.1%
52-week high
$10.85
52-week low
$3.31
Change from 52-week high
-11.6%
Change from 52-week low
+189.7%
Annualized volatility
71.6%
Annualized volatility (3M)
73.6%
Beta
0.6
RSI (14D)
56.0
Price vs SMA 50
+2.2%
Price vs SMA 200
+40.4%
Avg volume (3M)
275,609
Relative volume
0.5
Average dollar volume
$2.65M

Company

3 metrics
Sector
Industrials
Industry
Staffing & Employment Services
Shares outstanding
30.44M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 572.0%
P / book
1.2
reciprocal yield 86.1%
FCF yield
-22.8%
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-19.2%

Historical valuation

8 metrics
P / E historical average (3Y)
26.8×
reciprocal yield 3.7%
P / E historical average (5Y)
25.3×
reciprocal yield 4.0%
EV / revenue historical average (3Y)
0.3×
reciprocal yield 308.4%
EV / revenue historical average (5Y)
0.3×
reciprocal yield 308.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
21.2%
Operating margin
-2.9%
Trailing 12 months
Net margin
-3.3%
Gross profit (TTM)
$358.54M
Operating profit (TTM)
−$48.58M
Net income (TTM)
−$56.62M
Trailing 12 months
Diluted EPS (TTM)
$-1.89
FCF margin
-4.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$56.18
Gross profit per diluted share (TTM)
$11.91
Operating profit per diluted share (TTM)
$-1.62
EBITDA per diluted share (TTM)
$-0.68
Net income per diluted share (TTM)
$-1.88
Operating cash flow per diluted share (TTM)
$-1.81
Free cash flow per diluted share (TTM)
$-2.24
Capital expenditures per diluted share (TTM)
$0.43
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.22
Book value per share
$9.16

Growth

11 metrics
Revenue growth YoY
+11.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.69B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.9%
Year over year · more shares
Revenue CAGR (3Y)
-10.5%
Revenue CAGR (5Y)
-2.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-22.2%
Return on assets
-9.1%
Debt / equity
—
Current ratio
2.3
EBITDA (TTM)
−$20.29M
Free cash flow (TTM)
−$67.44M
Quick ratio
2.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$23.25M
Total assets
$622.96M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$54.49M
Capital expenditures (TTM)
$12.95M
R&D (TTM)
—
SG&A (TTM)
$357.80M
Stock compensation (TTM)
$6.68M
R&D / revenue
—
Stock compensation / revenue
0.4%

Ownership (13F)

9 metrics
13F filers
113
13F filer change QoQ
+8
Institutional ownership
85.0%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
41.8%
Private-fund adviser ownership
39.1%
Active holders' share change QoQ
-2.1%
Holder tenure
16.7
Price vs estimated holder cost
-23.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.0%

Short interest

3 metrics
Short interest
1.4%
Latest settlement · 2.1 days to cover
Days to cover
2.1d
Short-squeeze score
52 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 768899 CUSIP 89785X101 13F (30d) 29 filings 29 filers Visit website Investor relations